You just read:

BMS' Orencia Plunges into the Fray of Battle for Alternative MOA for Psoriatic Arthritis with Recent FDA Approval.... Can it Find a Unique Space to Play?

News provided by

Spherix Global Insights

Jul 06, 2017, 18:07 ET